Secondary analysis of clinical trials-a cautionary note

Progress in Cardiovascular Diseases

Volumn 54, Issue 4, 2012, Pages 335-337

  Marler, John R ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Clinical trial; Methodology; Secondary analysis

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); DATA ANALYSIS; DRUG MEGADOSE; HEART INFARCTION; HUMAN; INFORMATION PROCESSING; LOW DRUG DOSE; MEDICAL INFORMATION; MEDICAL PRACTICE; METHODOLOGY; PUBLISHING; RISK ASSESSMENT;

CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; HUMANS; SELECTION BIAS;

EID: 84855410096     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2011.09.006     Document Type: Article

References (10)

1. Guyatt G.H., Sackett D.L., Sinclair J.C., et al. Users guides to the medical literature IX. A method for grading health-care recommendations. JAMA 1995, 274:1800-1804.
2. Friedman L.M., Furberg C., Demets D.L. Fundamentals of clinical trials 1998, Springer-Verlag, New York, NY. 3rd. ed.
3. Fleming T.R. Clinical trials: discerning hype from substance. Annals Intern Med 2010, 153:400-406.
4. Sun X., Briel M., Walter S.D., et al. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ 2010, 340.
5. Oxman A.D., Guyatt G.H. A consumers guide to subgroup analyses. Annals Intern Med 1992, 116:78-84.
6. Assmann S.F., Pocock S.J., Enos L.E., et al. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000, 355:1064-1069.
7. Demets D.L., Califf R.M. Lessons learned from recent cardiovascular clinical trials: part I. Circulation 2002, 106:746-751.
8. Taylor D.W., Barnett H.J.M., Haynes R.B., et al. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. Lancet 1999, 353:2179-2184.
9. Sleight P. Debate: subgroup analyses in clinical trials: fun to look at-but don't believe them!. Curr Control Trials Cardiovasc Med 2000, 1:25-27.
10. Hernandez A.V., Boersma E., Murray G.D., et al. Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading?. Am Heart J 2006, 151:257-264.